Nicotine Polacrilex Lozenge
Product Images NDC 43598-484

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 43598-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton1 (Carton1)

Carton1 (Carton1)
This is a drug fact sheet containing information about the use of nicotine polacrilex lozenge as a smoking cessation aid. The lozenge reduces withdrawal symptoms including nicotine cravings associated with quitting smoking. The product is not recommended for use by pregnant or breastfeeding women and may adversely affect those with certain health conditions such as sodium-restricted diets, heart disease, high blood pressure, ulcers, and diabetes. Allergic reactions may occur. The directions for using the lozenge are described and it is recommended to use the product as part of a support program. The product is not for sale to individuals under 18 years old and proof of age is required. The tamper-evident feature warns not to use the product if the seal is broken or missing. There are three containers of 24 lozenges available for purchase.*
FDA Label Image

Carton2 (Carton2)

Carton2 (Carton2)
This is a label for a drug called Nicotine Polacrilex Lozenge, which is a stop smoking aid. It contains 4mg of nicotine per lozenge and is intended to help reduce withdrawal symptoms associated with quitting smoking. It comes with warnings for pregnant women, those with certain medical conditions, and individuals using other medications such as prescription drugs for depression or asthma. It provides detailed instructions for proper usage, including the recommended dosage and duration of use. The product is manufactured by Dr. Reddy's Laboratories and distributed by GlaxoSmithKline Consumer Healthcare.*
FDA Label Image

Container1 (Container1)

Container1 (Container1)
FDA Label Image

Container2 (Container2)

Container2 (Container2)
FDA Label Image

Figure (Figure)

Figure (Figure)
This text seems to be related to a smoking cessation program that involves the use of lozenges. The recommended frequency of lozenge intake varies depending on the week of the program, with a higher frequency at the beginning and a lower frequency later on. The text also mentions a period of 12 weeks after the quit date, though it is unclear what actions should be taken at that time.*
FDA Label Image

Pic1 (Pic1)

Pic1 (Pic1)
The wallet card provides contact information for individuals seeking help from different associations such as the American Lung Association, American Cancer Society, and American Heart Association. The card also suggests to seek help from a friend who has quit smoking to achieve smoking cessation.*
FDA Label Image

Pic2 (Pic2)

Pic2 (Pic2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.